April 3 (Bloomberg) -- Solazyme Inc., which develops oil products from genetically modified algae, rose the most in more than four months after announcing a joint venture with Bunge Ltd. to build a plant in Brazil.
Solazyme climbed 12 percent to $16.03 at the close in New York, the most since Nov. 16.
The facility will be capable of producing 100,000 metric tons of oil a year and be built next to Bunge’s Moema sugar-cane mill, the two companies said in a statement today. It will begin operating in the second half of 2013 and costs, which weren’t disclosed, will be split between the companies.
The plant will use Bunge’s sugar-cane supply and technology developed by South San Francisco, California-based Solazyme to produce oil that may be sold to the fuel and chemicals industries, according to the statement.
To contact the reporter on this story: Justin Doom in New York at email@example.com
To contact the editor responsible for this story: Reed Landberg at firstname.lastname@example.org